• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biolase, Inc. - Common Stock (NQ:BIOL)

0.1290 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biolase, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
BIOLASE Voluntarily Initiates Chapter 11 Proceedings
October 01, 2024
Via ACCESSWIRE
News headline image
BIOL Stock Earnings: Biolase Misses EPS, Misses Revenue for Q2 2024 ↗
August 09, 2024
BIOL stock results show that Biolase missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
BIOLASE Reports 2024 Second Quarter Results; Achieves 40% Gross Margin as Global Consumable Sales Strengthen
August 08, 2024
Via ACCESSWIRE
News headline image
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
July 17, 2024
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
June 19, 2024
 
Via Benzinga
News headline image
Biolase Reports 2024 First Quarter Results; Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability
May 13, 2024
Via ACCESSWIRE
News headline image
Recap: Biolase Q4 Earnings ↗
March 21, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
June 19, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
June 18, 2024
 
Via Benzinga
News headline image
BIOLASE Announces Delisting from Nasdaq
June 18, 2024
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
June 18, 2024
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
June 18, 2024
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning! 
Via InvestorPlace
News headline image
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
May 14, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
May 14, 2024
 
Via Benzinga
News headline image
Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗
May 14, 2024
 
Via Benzinga
News headline image
BIOL Stock Earnings: Biolase Misses EPS, Beats Revenue for Q1 2024 ↗
May 13, 2024
BIOL stock results show that Biolase missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
BIOLASE to Report First Quarter 2024 Results on May 13, 2024
May 06, 2024
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
April 11, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
April 10, 2024
 
Via Benzinga
News headline image
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
March 22, 2024
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
March 22, 2024
 
Via Benzinga
News headline image
Dow Dips 200 Points; Nike Shares Fall After Q3 Results ↗
March 22, 2024
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 200 points. The Dow traded down 0.54% to 39,565.50 while the NASDAQ rose 0.04% to 16,408.74. The S&P 500 also... 
Via Benzinga
Topics Stocks
News headline image
Why BIOLASE Shares Are Surging Friday ↗
March 22, 2024
BIOLASE, Inc. shares rise 31% after better-than-expected FY23 EPS results, strong revenue growth expected in 2024 due to increased laser adoption. 
Via Benzinga
News headline image
US Stocks Edge Lower; FedEx Posts Upbeat Earnings ↗
March 22, 2024
U.S. stocks traded slightly lower this morning. Following the market opening Friday, the Dow traded down 0.06% to 39,758.88 while the NASDAQ fell 0.10% to 16,385.60. The S&P 500 also fell, dropping,... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
March 22, 2024
 
Via Benzinga
News headline image
Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗
March 22, 2024
Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion 
Via Benzinga
News headline image
BIOL Stock Earnings: Biolase Beats EPS, Misses Revenue for Q4 2023 ↗
March 21, 2024
BIOL stock results show that Biolase beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
March 21, 2024
 
Via Benzinga
News headline image
Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024
March 21, 2024
Via ACCESSWIRE
News headline image
Earnings Scheduled For March 21, 2024 ↗
March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap